Evaluating lurasidone as a treatment option for bipolar disorder-Reference-Cited by-同舟云学术

Evaluating lurasidone as a treatment option for bipolar disorder

Published:2020-01-19 Issue:3 Volume:21 Page:253-260
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ali Ziad¹,Tegin Cunyet¹,El-Mallakh Rif S.¹

Affiliation:

1. Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1695777

Reference44 articles.

1. The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010

2. Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

3. Neuropsychology of bipolar disorder

4. The prevalence and burden of bipolar depression

5. Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-02

2. Medications for Bipolar Disorder;Tasman’s Psychiatry;2024

3. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone;Biomedicine & Pharmacotherapy;2023-12

4. Medications for Bipolar Disorder;Tasman’s Psychiatry;2023

5. Designing the minimum data set of bipolar disorder: A basis for introducing the effective factors in managing, controlling, and monitoring the bipolar disorder;Journal of Education and Health Promotion;2022